-
1
-
-
0026727160
-
New antimetabolites in the treatment of human malignancies
-
Cheson, B. D. New antimetabolites in the treatment of human malignancies. Semin Oncol. 19: 695-706, 1992.
-
(1992)
Semin Oncol.
, vol.19
, pp. 695-706
-
-
Cheson, B.D.1
-
2
-
-
0014347896
-
Arabinosyl cytosine: A useful agent in the treatment of acute leukemia in adults
-
Ellison, R. R., Holland, J. F., and M., W. Arabinosyl cytosine: a useful agent in the treatment of acute leukemia in adults, Blood. 32: 507-523, 1968.
-
(1968)
Blood.
, vol.32
, pp. 507-523
-
-
Ellison, R.R.1
Holland, J.F.2
DeM, W.3
-
3
-
-
0029956950
-
Oral cladribine as primary therapy for patients with B-cell chronic lymphocytic leukemia
-
Juliusson, G., Christiansen, I., Hansen, M. M., Johnson, S., Kimby, E., Elmhorn-Rosenborg, A., and Liliemark, J. Oral cladribine as primary therapy for patients with B-cell chronic lymphocytic leukemia, J Clin Oncol. 14: 2160-2166, 1996.
-
(1996)
J Clin Oncol.
, vol.14
, pp. 2160-2166
-
-
Juliusson, G.1
Christiansen, I.2
Hansen, M.M.3
Johnson, S.4
Kimby, E.5
Elmhorn-Rosenborg, A.6
Liliemark, J.7
-
4
-
-
0027200169
-
Long-term follow-up of patients with chronic lymphocytic leukemia treated with fludarabine as a single agent
-
Keating, M. J., O'Brien, S., Kantarjian, H., Plunkett, W., Estey, E., Koller, C., Beran, M., and Freireich, E. J. Long-term follow-up of patients with chronic lymphocytic leukemia treated with fludarabine as a single agent, Blood. 11: 2878-2884, 1993.
-
(1993)
Blood.
, vol.11
, pp. 2878-2884
-
-
Keating, M.J.1
O'Brien, S.2
Kantarjian, H.3
Plunkett, W.4
Estey, E.5
Koller, C.6
Beran, M.7
Freireich, E.J.8
-
5
-
-
27844461321
-
-
In: American Society of Hematology, San Diego
-
Tesch, H., Santoro, A., Fiedler, F., Bonadonna, G., Bredenfeld, H., Oliva, C., Buksmaui, S., Sieber, M., and Diehl, V. Phase 11 study of gemcitabine in pretreated Hodgkin's disease results of a multicenter study. In: American Society of Hematology, San Diego, 1997.
-
(1997)
Phase 11 Study of Gemcitabine in Pretreated Hodgkin's Disease Results of A Multicenter Study
-
-
Tesch, H.1
Santoro, A.2
Fiedler, F.3
Bonadonna, G.4
Bredenfeld, H.5
Oliva, C.6
Buksmaui, S.7
Sieber, M.8
Diehl, V.9
-
6
-
-
0025116531
-
Substrate-specific deoxycytidine kinase deficiency in 1-b-D-arabinofuranosylcytosineresistant leukemic cells
-
Richel, D. J., Colly, L. P., Arkesteijn, G. J. A., Arentsen-Honders, M. W., Kerster, M. G. D., ter Riet, P. M., and Willemze, R. Substrate-specific deoxycytidine kinase deficiency in 1-b-D-arabinofuranosylcytosineresistant leukemic cells, Cancer Res. 50: 6515-6519, 1990.
-
(1990)
Cancer Res.
, vol.50
, pp. 6515-6519
-
-
Richel, D.J.1
Colly, L.P.2
Arkesteijn, G.J.A.3
Arentsen-Honders, M.W.4
Kerster, M.G.D.5
Ter Riet, P.M.6
Willemze, R.7
-
7
-
-
0028157609
-
Resistance to cytosine arabinoside in acute leukemia: The significance of mutations in CTP synthetase
-
Whelan, J., Smith, T., Phear, G., Rohatiner, A., Lister, A., and Meuth, M. Resistance to cytosine arabinoside in acute leukemia: the significance of mutations in CTP synthetase. Leukemia. 8: 264-265, 1994.
-
(1994)
Leukemia.
, vol.8
, pp. 264-265
-
-
Whelan, J.1
Smith, T.2
Phear, G.3
Rohatiner, A.4
Lister, A.5
Meuth, M.6
-
8
-
-
0007844316
-
Cloning of a human nucleoside transporter implicated in the cellular uptake of adenosine and chemotherapeutic drugs
-
Griffiths, M., Beaumont, N., Yao, S. Y. M., Sundaram, M., Boumah, C. E., Davies, A., Kwong, F. Y. P., Coe, I., Cass, C. E., Young, J. D., and Baldwin, S. A. Cloning of a human nucleoside transporter implicated in the cellular uptake of adenosine and chemotherapeutic drugs. Nature Med. 3: 89-93, 1997.
-
(1997)
Nature Med.
, vol.3
, pp. 89-93
-
-
Griffiths, M.1
Beaumont, N.2
Yao, S.Y.M.3
Sundaram, M.4
Boumah, C.E.5
Davies, A.6
Kwong, F.Y.P.7
Coe, I.8
Cass, C.E.9
Young, J.D.10
Baldwin, S.A.11
-
9
-
-
0029835821
-
Evidence for the involvement of ecto-5'-nucleotidase (CD73) in drug resistance
-
Ujhazy, P., Berleth, E. S., Pietkiewicz, J. M, Kitano, H., Skaar, J. R., Ehrke, M. J., and Mihich, E. Evidence for the involvement of ecto-5'-nucleotidase (CD73) in drug resistance. Int J Cancer. 68: 493-500, 1996.
-
(1996)
Int J Cancer.
, vol.68
, pp. 493-500
-
-
Ujhazy, P.1
Berleth, E.S.2
Pietkiewicz, J.M.3
Kitano, H.4
Skaar, J.R.5
Ehrke, M.J.6
Mihich, E.7
-
10
-
-
0023913190
-
Molecular mechanisms of drug resistance involving ribonucleotide reductase: Hydroxyurea resistance in a series of clonally related mouse cell lines selected in the presence of increasing drug concentrations
-
Choy, B. K., Mc Clarty, G. A., Chan, A. K., Thelander, L., and Wright, J. A. Molecular mechanisms of drug resistance involving ribonucleotide reductase: hydroxyurea resistance in a series of clonally related mouse cell lines selected in the presence of increasing drug concentrations, Cancer Res. 48: 2029-2035, 1988.
-
(1988)
Cancer Res.
, vol.48
, pp. 2029-2035
-
-
Choy, B.K.1
Mc Clarty, G.A.2
Chan, A.K.3
Thelander, L.4
Wright, J.A.5
-
11
-
-
0031020978
-
2 chloro deoxyadenosine inhibits activity of adenosine deaminase and S-adenosylhomocysteine hydrolase in patients with chronic lymphocytic leukemia
-
Warzocha, K., Fabianowska-Majewska, K., Blonski, J., Krykowski, E., and Robak, T. 2 chloro deoxyadenosine inhibits activity of adenosine deaminase and S-adenosylhomocysteine hydrolase in patients with chronic lymphocytic leukemia, Eur J Cancer. 33: 170-173, 1996.
-
(1996)
Eur J Cancer.
, vol.33
, pp. 170-173
-
-
Warzocha, K.1
Fabianowska-Majewska, K.2
Blonski, J.3
Krykowski, E.4
Robak, T.5
-
12
-
-
0030877223
-
Incorporation of fludarabine and 1-β-D-arabinofuranosylcytosine 5'-triphosphates by DNA polymerase α: Affinity, interaction and consequences
-
Gandhi, V., Huang, P., Chapman, A. J., Chen, F., and Plunkett, W. Incorporation of fludarabine and 1-β-D-arabinofuranosylcytosine 5'-triphosphates by DNA polymerase α: affinity, interaction and consequences. Clin Cancer Res. 3: 1347-1355, 1997.
-
(1997)
Clin Cancer Res.
, vol.3
, pp. 1347-1355
-
-
Gandhi, V.1
Huang, P.2
Chapman, A.J.3
Chen, F.4
Plunkett, W.5
|